Review of Piperacillin Sodium and Tazobactam Sodium for Injection by Huabei Pharmaceutical

Medical Network News on March 17 A few days ago, Huabei Pharmaceutical's piperacillin sodium and tazobactam sodium for injection passed the consistency evaluation and was the first in China
.
According to data from Minai.
com, the market size of the terminal piperacillin sodium tazobactam in China's public medical institutions in 2019 exceeded 8 billion yuan, ranking first in the TOP10 generic drugs for systemic antibacterial drugs
.
Source: Piperacillin Sodium for Injection on the official website of the State Drug Administration and Tazobactam sodium is a compound anti-infective drug composed of piperacillin (semi-synthetic penicillin antibiotic) and tazobactam (β-lactamase inhibitor).
It is suitable for moderate and severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin but sensitive to piperacillin and tazobactam
.
According to data from Minai.
com, in 2019, the sales of piperacillin sodium and tazobactam sodium for terminal injection in China's urban public hospitals , county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) exceeded 8 billion yuan.
A year-on-year increase of 2.
4%, the growth rate has declined in the first half of 2020, but in the competition pattern of general-name drugs for systemic antibacterial drugs , piperacillin sodium and tazobactam still ranks first with a market share of 5.
76%
.
Application status of consistency evaluation of piperacillin sodium for injection and tazobactam sodium (including new classification and production) Source: Meinenet MED2.
0 Chinese drug review database is currently in the layout of piperacillin sodium for injection and tazobactam sodium consistency evaluation of enterprises small, smooth over North China pharmaceutical product assessment, the first domestic; Qilu pharmaceutical has submitted both to evaluate the agreement supplementary application, assuming new classification newspaper production, it is still in review and approval
.
According to data from Minei.
com, there are currently 20 systemic antibacterial injections (based on the name of the drug) that have passed or deemed to have passed the consistency evaluation.
Among them, Moxifloxacin Hydrochloride and Sodium Chloride Injection and Ceftriaxone Sodium for Injection have passed the evaluation.
5 and above
.
Source: Minei.
com database, official website of the State Food and Drug Administration.
Note: Statistics are as of March 16, if any omissions, please correct me!